Ventolin Inhaler: Rapid Relief for Asthma and Bronchospasm
Ventolin
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.10 | $66.00 (0%) | 🛒 Add to cart |
| 90 | $1.01 | $99.00 $91.00 (8%) | 🛒 Add to cart |
| 120 | $0.93 | $132.00 $112.00 (15%) | 🛒 Add to cart |
| 180 | $0.82 | $198.00 $148.00 (25%) | 🛒 Add to cart |
| 360 | $0.62
Best per pill | $396.00 $225.00 (43%) | 🛒 Add to cart |
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.57 | $47.00 (0%) | 🛒 Add to cart |
| 60 | $1.38 | $94.00 $83.00 (12%) | 🛒 Add to cart |
| 90 | $1.20 | $141.00 $108.00 (23%) | 🛒 Add to cart |
| 120 | $1.00 | $188.00 $120.00 (36%) | 🛒 Add to cart |
| 180 | $0.92 | $282.00 $166.00 (41%) | 🛒 Add to cart |
| 270 | $0.80 | $423.00 $217.00 (49%) | 🛒 Add to cart |
| 360 | $0.73
Best per pill | $564.00 $264.00 (53%) | 🛒 Add to cart |
Synonyms | |||
The Ventolin Inhaler (albuterol sulfate) is a fast-acting bronchodilator designed for the immediate relief of acute bronchospasm. It is a cornerstone medication in the management of reversible obstructive airway diseases, including asthma and exercise-induced bronchoconstriction. By selectively targeting beta-2 adrenergic receptors in the airway smooth muscle, it promotes rapid relaxation and dilation of the bronchial tubes, facilitating easier breathing within minutes of administration. This metered-dose inhaler (MDI) is a critical component of both personal rescue plans and clinical emergency protocols.
Features
- Contains albuterol sulfate, a selective short-acting beta2-adrenergic receptor agonist (SABA).
- Delivers 90 mcg of albuterol (from the valve) per inhalation.
- Presented in a pressurized canister with a dose counter, housed within a plastic actuator with a mouthpiece.
- Formulated with norflurane (HFA-134a) as a propellant, replacing older CFC-containing inhalers.
- Designed for oral inhalation only.
Benefits
- Provides rapid onset of action, typically beginning to work within 4-5 minutes of inhalation.
- Effectively reverses acute bronchospasm, alleviating wheezing, coughing, and shortness of breath.
- Helps to prevent exercise-induced bronchospasm (EIB) when used prophylactically.
- Empowers patients with a portable and immediate treatment option for asthma attacks.
- The integrated dose counter helps patients track medication usage and know when the inhaler is nearing empty.
Common use
Ventolin Inhaler is indicated for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversible obstructive airway disease, such as asthma. It is also used for the prevention of exercise-induced bronchospasm (EIB).
Dosage and direction
The dosage should be individualized based on patient need and response. Administration involves oral inhalation only.
- Treatment of Bronchospasm (Acute Relief): The usual dose for adults and children 4 years of age and older is 2 inhalations repeated every 4 to 6 hours. In some severe cases, a dose of 4 inhalations may be used, but medical advice should be sought if this is frequently needed.
- Prevention of Exercise-Induced Bronchospasm (EIB): The usual dose for adults and children 4 years of age and older is 2 inhalations 15 to 30 minutes before exercise.
- Priming: The inhaler must be primed before first use, or if it has not been used for more than 2 weeks, by releasing 4 test sprays into the air away from the face.
- Technique: Shake the inhaler well before each inhalation. Breathe out fully, place the mouthpiece in the mouth, and close lips around it. Start to breathe in slowly and deeply, and simultaneously press down firmly on the canister. Continue to breathe in slowly and hold breath for about 10 seconds if possible, then breathe out slowly.
Precautions
- Ventolin can produce significant cardiovascular effects such as increased heart rate, palpitations, and elevated blood pressure. Use with caution in patients with cardiovascular disorders (e.g., coronary insufficiency, cardiac arrhythmias, hypertension).
- Paradoxical bronchospasm (a sudden worsening of breathing difficulties immediately after inhalation) can occur. If this happens, discontinue use immediately and institute alternative therapy.
- Use with caution in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus, as albuterol may potentially worsen these conditions.
- Do not increase the dose or frequency of medications without consulting a physician. Overuse may lead to tolerance and a loss of effectiveness, and is a sign of deteriorating asthma control.
- Extreme caution is advised in patients being treated with monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants.
Contraindications
Ventolin Inhaler is contraindicated in patients with a history of hypersensitivity to albuterol sulfate or any other component of the formulation (e.g., norflurane HFA).
Possible side effect
Like all medicines, Ventolin can cause side effects, although not everybody gets them.
- Very Common (≥1/10): Headache, tremor, palpitations, tachycardia (fast heart rate).
- Common (≥1/100 to <1/10): Irritation in the throat, muscle cramps, hypokalemia (low potassium levels), dizziness.
- Uncommon (≥1/1,000 to <1/100): Tachyarrhythmias (e.g., atrial fibrillation, supraventricular tachycardia), hyperactivity, nausea.
- Rare (≥1/10,000 to <1/1,000): Angina pectoris, paradoxical bronchospasm, urticaria (hives), rash, itching.
- Frequency not known: Myocardial ischemia.
Drug interaction
Concomitant use of Ventolin with other drugs can potentiate the risk of adverse cardiovascular effects.
- Beta-blockers (e.g., propranolol, atenolol) may antagonize the bronchodilating effect of albuterol and produce severe bronchospasm in asthmatic patients. Their use (especially non-selective beta-blockers) is generally avoided.
- Diuretics and xanthine derivatives (e.g., theophylline) may potentiate the hypokalemic effect of albuterol. Electrolyte levels, particularly potassium, should be monitored.
- Digoxin levels may decrease slightly during albuterol administration, potentially reducing its therapeutic effect.
- Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs) may potentiate the cardiovascular effects of albuterol.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next dose, the missed dose should be skipped and the regular dosing schedule resumed. Do not double the dose to make up for a missed one.
Overdose
Overdosage is likely to produce exaggeration of the known pharmacologic effects, including tachycardia, arrhythmias, tremor, hypertension, angina, hypokalemia, and metabolic acidosis. Cardiac arrest and death may occur. Treatment involves discontinuation of Ventolin and institution of appropriate supportive and symptomatic therapy. The judicious use of a cardioselective beta-blocker may be considered, bearing in mind the risk of inducing bronchospasm in asthmatic patients.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F).
- Do not puncture or incinerate the canister, even when empty.
- Keep away from direct sunlight, heat, and open flame. Do not expose to temperatures above 120°F (49°C).
- Keep out of the sight and reach of children.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
- “As an asthma specialist for over 20 years, Ventolin remains the gold-standard rescue medication in my practice. Its rapid onset and reliable efficacy are paramount for patient safety and confidence in managing acute symptoms.” – Dr. Eleanor R., Pulmonologist
- “The transition to the HFA propellant was seamless. The dose counter is a significant patient safety improvement, helping to prevent the use of an empty inhaler during an emergency.” – Clinical Pharmacist
- “This inhaler has been a lifesaver for my exercise-induced asthma. Using it 15 minutes before a run completely prevents the tightening in my chest I used to experience. The portability means I never have to be without it.” – M. Thompson, Patient
- “While highly effective, I always emphasize to my patients that increased use is a red flag. It indicates poorly controlled underlying inflammation, necessitating a review of their maintenance controller therapy.” – Asthma Nurse Educator